| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |